January 22, 2017 1:45 PM ET


Company Overview of Afferent Pharmaceuticals, Inc.

Key Executives for Afferent Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Kathleen Sereda Glaub MBA23 RelationshipsChief Executive Officer and Director62
Anthony P. Ford Ph.D.No RelationshipsCo-Founder and Chief Scientific Officer--
Michael M. Kitt M.D.8 RelationshipsChief Medical Officer66

Afferent Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Kevin P. Starr 65 RelationshipsDecibel Therapeutics, Inc.53
Kathleen Sereda Glaub MBA 23 RelationshipsAfferent Pharmaceuticals, Inc.62
Liam Ratcliffe M.D., Ph.D. 87 RelationshipsNew Leaf Venture Partners, L.L.C.53
Jesse I. Treu Ph.D. 65 RelationshipsDomain Associates, L.L.C.69
Steven B. Abramson M.D. 29 RelationshipsNYU Langone Medical Center LLC--
View All Board Members

Afferent Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
Afferent Pharmaceuticals, Inc. CEO Compensation
Industry Average


Dimension Therapeutics, Inc. Elects John Hohneker to the Board of Directors
January 20, 2017 9:31 PM ET
T2 Biosystems, Inc. Announces Resignation of Joshua Bilenker as Class II Director and from Nominating and Corporate Governance Committee
January 20, 2017 9:01 PM ET
Luminor Medical Technologies Inc. Appoints Daniel Cloutier to the Board of Directors
January 20, 2017 1:04 PM ET
Jiangsu Sihuan Bioengineering Co., Ltd Announces Executive Changes
January 20, 2017 4:31 AM ET
Polynovo Limited Appoints Gavin Smith as Joint Company Secretary
January 20, 2017 1:12 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Afferent Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.